This topic contains 0 replies, has 1 voice, and was last updated by 
-
Posts
-
Xadago (safinamide) has been approved in Australia as an add-on therapy to a levodopa/carbidopa regimen for adults with idiopathic Parkinson’s disease. Click here to learn more.
What are your thoughts on this news?
You must be logged in to reply to this topic.
